FPHAX Holdings Information

FPHAX is a mutual fund with a total of 57 individual holdings. The top holdings are Eli Lilly and Company stock at 28.78%, GSK plc at 8.17%, Viatris at 5.45%, UCB SA at 5.09%, and Merck & Co. at 4.74%.

Total Holdings

Top 10 Percentage

73.76%

Asset Class

Equity

Fund Category

Health

Assets

1.60B

Forward PE Ratio

15.69

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	28.78%	390,801
2	GSK	GSK plc	8.17%	2,425,160
3	VTRS	Viatris Inc.	5.45%	5,032,300
4	EBR: UCB	UCB SA	5.09%	260,100
5	MRK	Merck & Co., Inc.	4.74%	599,336
6	SWX: ROP	Roche Holding AG	4.54%	161,630
7	LEGN	Legend Biotech Corporation	4.53%	2,504,500
8	LON: AZN	AstraZeneca PLC	4.22%	341,350
9	ELAN	Elanco Animal Health Incorporated	4.15%	2,611,000
10	JAZZ	Jazz Pharmaceuticals plc	4.09%	259,600
11	GILD	Gilead Sciences, Inc.	3.97%	442,800
12	JNJ	Johnson & Johnson	3.77%	251,200
13	RPRX	Royalty Pharma plc	2.67%	718,900
14	MRNA	Moderna, Inc.	1.57%	499,200
15	NTLA	Intellia Therapeutics, Inc.	1.19%	1,266,200
16	BEAM	Beam Therapeutics Inc.	1.10%	500,600
17	AXSM	Axsome Therapeutics, Inc.	1.08%	69,000
18	BNTX	BioNTech SE	1.04%	163,253
19	XENE	Xenon Pharmaceuticals Inc.	0.82%	226,000
20	OCUL	Ocular Therapeutix, Inc.	0.80%	1,331,717
21	IDXX	IDEXX Laboratories, Inc.	0.61%	16,200
22	STO: SOBI	Swedish Orphan Biovitrum AB (publ)	0.54%	170,200
23	PTCT	PTC Therapeutics, Inc.	0.54%	110,000
24	CAPR	Capricor Therapeutics, Inc.	0.46%	231,300
25	KYMR	Kymera Therapeutics, Inc.	0.46%	84,500

Showing 25 of 57 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026